Loading clinical trials...
Loading clinical trials...
NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer: a Randomized Phase II Trial
Conditions
Interventions
Capecitabine
FOLFOX regimen (oxaliplatin/leucovorin/5FU)
+1 more
Locations
1
Denmark
Vejle Hospital
Vejle, Denmark
Start Date
March 1, 2017
Primary Completion Date
December 31, 2018
Completion Date
December 31, 2024
Last Updated
September 28, 2017
NCT04704661
NCT06696768
NCT06662786
NCT05489211
NCT06625775
NCT04657068
Lars Henrik Jensen, MD
CONTACT
Lead Sponsor
Zealand University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions